Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Septic Shock Patients
100%
Sepsis Bundles
100%
Impella 5.0
100%
Extracorporeal Membrane Oxygenation Circuit
100%
Improved Outcomes
100%
Severe Sepsis
100%
Retrospective Analysis
100%
Surgical ICU
100%
Massive Bleeding
100%
Recombinant Activated Factor VII (rFVIIa)
100%
Cardiac Surgery Patients
100%
Cardiogenic Shock
100%
Safety Outcomes
100%
Efficacy Outcomes
100%
Length of Stay
80%
Institute for Healthcare Improvement
60%
Septic Shock
60%
Intensivist
60%
Cardiovascular ICU
60%
Left Ventricular Assist Device
50%
Crit
40%
Sepsis Protocol
40%
Sepsis
40%
Surviving Sepsis Campaign
40%
Red Blood Cells
33%
Older Men
25%
Successful Placement
25%
Aorta
25%
Severe Heart Failure
25%
Cardiovascular Surgery Patients
25%
High-risk Percutaneous Coronary Intervention
25%
Cardiovascular Surgery
25%
Long-term Support
25%
Left Ventricle
25%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
25%
Surgical Placement
25%
Shock Patient
20%
Angus
20%
Educational Awareness
20%
Surgical Patients
20%
ICU Patients
20%
Cost Savings
20%
Team Approach
20%
Inclusion Criteria
20%
Refractory Bleeding
16%
Product Consumption
8%
Massive Blood Loss
8%
Massive Transfusion
8%
Fresh Frozen Plasma
8%
Cell Reduction
8%
Nursing and Health Professions
Recombinant Blood Clotting Factor 7a
100%
Septic Shock
100%
Sepsis
100%
Surgical Intensive Care Unit
100%
Efficacy
100%
Cardiovascular Surgery
100%
Heart Surgery
100%
Erythrocyte
66%
Bleeding
50%
Length of Stay
33%
Intensivist
25%
Coronary Care Unit
25%
Cryoprecipitate
16%
Clinical Outcome
16%
Optimal Drug Dose
16%
Teaching Hospital
16%
Tertiary Health Care
16%
Fresh Frozen Plasma
16%
Cost Control
8%
Intensive Care Unit
8%
Medicine and Dentistry
Recombinant Blood Clotting Factor 7a
100%
Left Ventricular Assist Device
100%
Extracorporeal Membrane Oxygenation
100%
Cardiovascular Surgery
100%
Heart Surgery
100%
Erythrocyte
66%
Left Ventricle
50%
Congestive Heart Failure
50%
Percutaneous Coronary Intervention
50%
Bleeding
50%
Blood Product
33%
Optimal Drug Dose
16%
Subgroup Analysis
16%
Fresh Frozen Plasma
16%
Tertiary Care
16%
Platelet
16%